Sevenfact® (coagulation factor VIIa (recombinant)-jncw)
for Hemophilia

Sevenfact (coagulation factor VIIa [recombinant]-jncw) is used to treat and prevent bleeding in people with hemophilia A or B with inhibitors. Sevenfact contains a synthetic version of factor VIIa, a blood protein that helps promote clotting in coordination with other clotting factors.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia